摘要
传统癌症疗法是受到一些明显的障碍,包括低效率、阻力、全身并发症等。利用近红外(NIR)非侵入性和靶向检测金纳米结构是非常有吸引力的,由于其独特的物理化学性质在NIR光谱下有特别强的吸收、散射和高表面积体积比以及活泼的表面化学性质可以被操纵,以表面改性和官能化提高生物相容性。在本综述中,光热治疗(PTT)的进展以及靶向投递抗癌剂的金纳米结构的主要应用将详细地介绍,并且影像指导的治疗和操作参数优化将是重点。随近红外光控靶向给药和/或光热消融的金纳米结构治疗下的转移也进行了简要讨论。这些金纳米结构为开发更好的癌症治疗策略铺平了道路。
关键词: 癌症治疗,药物投递系统,金纳米结构,影像指导治疗,转移,近红外(NIR)光,光热治疗(PTT)
图形摘要
Current Cancer Drug Targets
Title:Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy
Volume: 15 Issue: 5
Author(s): Yaping Jiang, Wei Fei, Xiao Cen, Yaling Tang and Xinhua Liang
Affiliation:
关键词: 癌症治疗,药物投递系统,金纳米结构,影像指导治疗,转移,近红外(NIR)光,光热治疗(PTT)
摘要: Traditional therapy for cancer is subject to some evident obstacles, including low effectiveness, resistance, systemic complication, etc. Gold nanostructures responsive to near-infrared (NIR) light are attractive for non-invasive and targeted therapy because of their unique physical properties especially strong absorption and scattering, and high surface area-to-volume ratio as well as the ease of which their surface chemistry can be manipulated to enhance biocompatibility surface modification and functionalization. In this Review, the progress of photothermal therapy (PTT) as well as the targeted delivery of anticancer agents as the predominant applications of gold nanostructures is detailed, with a focus on imaging-guided therapy and optimizing operational parameters. The NIR light-controlled targeted delivery and/or photothermal ablation of gold nanostructures in the treatment of metastasis are also briefly discussed. These gold nanostructures pave the way for developing better therapeutic strategies of cancer.
Export Options
About this article
Cite this article as:
Yaping Jiang, Wei Fei, Xiao Cen, Yaling Tang and Xinhua Liang , Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy, Current Cancer Drug Targets 2015; 15 (5) . https://dx.doi.org/10.2174/1568009615666150407125333
DOI https://dx.doi.org/10.2174/1568009615666150407125333 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers
Current Pharmaceutical Design Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat
Drug Metabolism Letters DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry Efficacy and Safety of Nonopioid Analgesics in Perioperative Pain Control
Current Drug Safety The Role of TRP Channels in Allergic Inflammation and its Clinical Relevance
Current Medicinal Chemistry Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Treatment of PSA only Recurrence of Prostate Cancer After Prior Local Therapy
Current Pharmaceutical Design Role of Epigenetics and Oxidative Stress in Gliomagenesis
CNS & Neurological Disorders - Drug Targets Fibroblast Growth Factor 2: From Laboratory Evidence to Clinical Application
Current Vascular Pharmacology The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging A Transporter Gene (Sodium Iodide Symporter) for Dual Purposes in Gene Therapy: Imaging and Therapy
Current Gene Therapy Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies
Current Medicinal Chemistry Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) Subject Index to Volume 3
Current Gene Therapy Angiogenesis: A Target for Cancer Therapy
Current Pharmaceutical Design Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science Inflammation and Cancer: In Medio Stat Nano
Current Medicinal Chemistry Chemically Functionalized Carbon Nanotubes: Emerging Vectors for Cell Therapy
Mini-Reviews in Medicinal Chemistry Potential Utility of Mycobacterium w Vaccine in Control of Tuberculosis
Current Respiratory Medicine Reviews Meet Our Editorial Board Member
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)